Ascent Wealth Partners’s Eli Lilly LLY Stock Holding History

Ascent Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.01M	Buy	8,706 +540	+7%	+$547K	0.93%	33
2025 Q4	$8.78M	Buy	8,166 +40	+0.5%	+$38.2K	1.01%	31
2025 Q3	$6.2M	Buy	8,126 +4,962	+157%	+$3.69M	0.72%	45
2025 Q2	$2.47M	Sell	3,164 -875	-22%	-$680K	0.3%	69
2025 Q1	$3.34M	Buy	4,039 +30	+0.7%	+$25K	0.45%	54
2024 Q4	$3.09M	Buy	4,009 +119	+3%	+$98.5K	0.42%	55
2024 Q3	$3.45M	Buy	3,890 +599	+18%	+$539K	0.48%	49
2024 Q2	$2.98M	Buy	3,291 +1,699	+107%	+$1.36M	0.44%	53
2024 Q1	$1.21M	Buy	+1,592	New	+$1.13M	0.18%	102

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ascent Wealth Partners's LLY Position: Q1 2026 in Review

Ascent Wealth Partners increased its Eli Lilly (LLY) stake by 6.6% in Q1 2026, buying an estimated $547K and bringing the position to 8,706 shares worth $8.01M. The position accounts for 0.93% of the portfolio, ranked #33.

Ascent Wealth Partners first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.78M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Ascent Wealth Partners held 8,706 shares of Eli Lilly worth $8.01M as of Q1 2026.
Ascent Wealth Partners bought 540 Eli Lilly shares in Q1 2026, an estimated $547K.
Eli Lilly made up 0.93% of Ascent Wealth Partners's portfolio in Q1 2026, its #33 holding.
Ascent Wealth Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Ascent Wealth Partners's Eli Lilly position peaked at $8.78M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ascent Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.